With the resignation of Scott Gottlieb, the speculations have gone very fast concerning the e-cigarette. Yet the arrival of the new interim commissioner at the Food and Drug Administration (FDA), Ned Sharpless could well cool the sector of the vape because the war against the so-called "epidemic" does not seem finished!
Last Tuesday, the Acting Commissioner of the FDA, Ned Sharplessstated that the administration would continue the efforts of its predecessor, Scott Gottlieb, to fight against smoking among young people.
« We will continue to focus on the need to end adult cigarette use and prevent children from starting", Said Sharpless at its first meeting among all FDA members.
Ned Sharpless, 52, was director of the National Cancer Institute from November 2017 until Scott Gottlieb left the 5 last April. He has long been an academic whose research focuses on the link between cancer and aging.
VITAL RESEARCH ON E-CIGARETTE TO REGULATE
The new commissioner said the FDA would lead vital research to ensure that it has the necessary data to make informed regulatory decisions about e-cigarettes. The goal is clearly to be able to reverse the growing epidemic of use of ENDS by young people ".
The FDA took control of the 2016 e-cigarette regulation, after extending its tobacco monitoring to electronic nicotine delivery systems. Last November, Scott Gottlieb said the teenage vape rate was an "epidemic" and triggered a major regulatory crackdown.
« Everyone agrees that there will be more regulation in the tobacco sector" , said Joe Grogan, director of the White House's Domestic Policy Council, in an interview with Bloomberg in March. " We are extremely concerned about the public health consequences of e-cigarette smoking and e-cigarette use »
Ned Sharpless assured staff that the FDA would not tolerate the marketing or sale of tobacco or e-cigarettes to less than 18 years.
source : Washingtonexaminer.com/